marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-13-2024
Synthetic Biologics Balance Sheet 2011-2024 | SYN
Annual Balance Sheet Synthetic Biologics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-22.5 M | -41.3 M | -65.8 M | -5.75 M | -14.3 M | -28.9 M | -17.1 M | -19.1 M | -20.8 M | -17.5 M | -14.6 M | -9.95 M | -6.68 M |
Long Term Debt |
162 K | 221 K | 1.4 M | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
487 K | 216 K | 124 K | 287 K | 249 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 186 K | 473 K | 302 K | 12.5 M | 492 K | 267 K | - | - | - | - |
Total Current Liabilities |
6.74 M | 7.06 M | 3.55 M | 2.97 M | 5.28 M | 3.38 M | 9.79 M | 19.8 M | 15.6 M | 9.59 M | 1.03 M | 395 K | 417 K |
Total Liabilities |
15.5 M | 17.3 M | 4.96 M | 3.15 M | 5.75 M | 3.69 M | 22.2 M | 20.2 M | 15.8 M | 9.59 M | 1.03 M | 395 K | 417 K |
Deferred Revenue |
906 K | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-309 M | -291 M | -271 M | -248 M | -236 M | -219 M | -194 M | -172 M | -145 M | -101 M | -81.3 M | -68.9 M | -51.9 M |
Total Assets |
55.2 M | 71.9 M | 70.4 M | 8.41 M | 17.2 M | 30.1 M | 18.8 M | 22.5 M | 30.8 M | 19.1 M | 16.3 M | 13.4 M | 7.48 M |
Cash and Cash Equivalents |
23.2 M | 41.8 M | 67.3 M | 6.23 M | 15 M | 28.9 M | 17.1 M | 19.1 M | 20.8 M | 17.5 M | 14.6 M | 9.95 M | 6.68 M |
Book Value |
39.7 M | 54.6 M | 65.4 M | 5.26 M | 11.5 M | 26.5 M | -3.41 M | 2.25 M | 15 M | 9.56 M | 15.2 M | 13 M | 7.06 M |
Total Shareholders Equity |
37 M | 51.8 M | 65.4 M | -4.77 M | 1.82 M | 17.1 M | -1.5 M | 3.84 M | 16.1 M | 9.56 M | 15.2 M | 13 M | 7.06 M |
All numbers in USD currency
Quarterly Balance Sheet Synthetic Biologics
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
1.16 M | 1.3 M | 1.44 M | 150 K | 153 K | 160 K | 221 K | 202 K | 216 K | 229 K | 1.4 M | 1.4 M | 1.43 M | 108 K | 186 K | 186 K | 186 K | 186 K | 473 K | 473 K | 473 K | 473 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
14.7 M | 14.6 M | 15.5 M | 17.7 M | 17.7 M | 17.3 M | 17.3 M | 20.5 M | 20.7 M | 21 M | 4.96 M | 4.56 M | 3.52 M | 2.23 M | 3.15 M | 3.15 M | 3.15 M | 3.15 M | 5.75 M | 5.75 M | 5.75 M | 5.75 M | 3.69 M | 3.69 M | 3.69 M | 3.69 M | 10.2 M | 10.2 M | 10.2 M | 10.2 M | 20.2 M | 20.2 M | 20.2 M | 20.2 M | 15.8 M | 15.8 M | 15.8 M | 15.8 M | 9.59 M | 9.59 M | 9.59 M | 9.59 M | 1.03 M | 1.03 M | 229 K | 1.03 M | 395 K | 395 K | 395 K | 443 K | 417 K | 417 K | 417 K | 417 K |
Deferred Revenue |
- | - | - | 525 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-323 M | -314 M | -309 M | -304 M | -301 M | -295 M | -291 M | -285 M | -281 M | -276 M | -271 M | -266 M | -263 M | -260 M | -248 M | -248 M | -248 M | -248 M | -236 M | -236 M | -236 M | -236 M | -219 M | -219 M | -219 M | -219 M | -194 M | -194 M | -194 M | -194 M | -172 M | -172 M | -172 M | -172 M | -145 M | -145 M | -145 M | -145 M | -101 M | -101 M | -101 M | -101 M | -81.3 M | -81.3 M | -81.3 M | -81.3 M | -68.9 M | -68.9 M | -68.9 M | -68.9 M | -51.9 M | -51.9 M | -51.9 M | -51.9 M |
Total Assets |
42.4 M | 48.7 M | 55.2 M | 61.5 M | 65.4 M | 67.9 M | 71.9 M | 78.7 M | 82.3 M | 89 M | 70.4 M | 75.1 M | 77.3 M | 79.1 M | 8.41 M | 8.41 M | 8.41 M | 8.41 M | 17.2 M | 17.2 M | 17.2 M | 17.2 M | 30.1 M | 30.1 M | 30.1 M | 30.1 M | 18.8 M | 18.8 M | 18.8 M | 18.8 M | 22.5 M | 22.5 M | 22.5 M | 22.5 M | 30.8 M | 30.8 M | 30.8 M | 30.8 M | 19.1 M | 19.1 M | 19.1 M | 19.1 M | 16.3 M | 16.3 M | 16.3 M | 16.3 M | 13.4 M | 13.4 M | 13.4 M | 13.4 M | 7.48 M | 7.48 M | 7.48 M | 7.48 M |
Cash and Cash Equivalents |
16.6 M | 18.3 M | 23.2 M | 31.2 M | 34.2 M | 36.1 M | 41.8 M | 50.5 M | 52.3 M | 56.7 M | 67.3 M | 72.1 M | 74.3 M | 76.9 M | 6.23 M | 6.23 M | 6.23 M | 6.23 M | 15 M | 15 M | 15 M | 15 M | 28.9 M | 28.9 M | 28.9 M | 28.9 M | 17.1 M | 17.1 M | 17.1 M | 17.1 M | 19.1 M | 19.1 M | 19.1 M | 19.1 M | 20.8 M | 20.8 M | 20.8 M | 20.8 M | 17.5 M | 17.5 M | 17.5 M | 17.5 M | 14.6 M | 14.6 M | 14.6 M | 14.6 M | 9.95 M | 10 M | 10 M | 9.6 M | 6.68 M | 5 M | 8.39 M | 6.68 M |
Book Value |
27.6 M | 34.1 M | 39.7 M | 43.9 M | 47.8 M | 50.6 M | 54.6 M | 58.1 M | 61.7 M | 68 M | 65.4 M | 70.6 M | 73.7 M | 76.8 M | 5.26 M | 5.26 M | 5.26 M | 5.26 M | 11.5 M | 11.5 M | 11.5 M | 11.5 M | 26.5 M | 26.5 M | 26.5 M | 26.5 M | 8.64 M | 8.64 M | 8.64 M | 8.64 M | 2.25 M | 2.25 M | 2.25 M | 2.25 M | 15 M | 15 M | 15 M | 15 M | 9.56 M | 9.56 M | 9.56 M | 9.56 M | 15.2 M | 15.2 M | 16 M | 15.2 M | 13 M | 13 M | 13 M | 13 M | 7.06 M | 7.06 M | 7.06 M | 7.06 M |
Total Shareholders Equity |
25.9 M | 31.4 M | 37 M | 41.2 M | 45 M | 47.9 M | 51.8 M | 56.4 M | 62.2 M | 68 M | 65.4 M | 70.6 M | 73.7 M | 76.8 M | -4.77 M | -4.77 M | -4.77 M | -4.77 M | 1.82 M | 1.82 M | 1.82 M | 1.82 M | 17.1 M | 17.1 M | 17.1 M | 17.1 M | -1.5 M | -1.5 M | -1.5 M | -1.5 M | 3.84 M | 3.84 M | 3.84 M | 3.84 M | 16.1 M | 16.1 M | 16.1 M | 16.1 M | 9.56 M | 9.56 M | 9.56 M | 9.56 M | 15.2 M | 15.2 M | 15.2 M | 15.2 M | 13 M | 13 M | 13 M | 13 M | 7.06 M | 7.06 M | 7.06 M | 7.06 M |
All numbers in USD currency